MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Block History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Block | ₹19,004 Cr | ₹4,540 Cr | ₹4,245 Cr | ₹3,583 Cr | ₹1,659 Cr |
What is the latest Net Block ratio of MANKIND PHARMA ?
| Year | Net Block |
|---|---|
| Mar2025 | ₹19,004 Cr |
| Mar2024 | ₹4,540 Cr |
| Mar2023 | ₹4,245 Cr |
| Mar2022 | ₹3,583 Cr |
| Mar2021 | ₹1,659 Cr |
How is Net Block of MANKIND PHARMA Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2025 | ₹19,004 Cr | 318.61 | |
| Mar2024 | ₹4,540 Cr | 6.94 | |
| Mar2023 | ₹4,245 Cr | 18.49 | |
| Mar2022 | ₹3,583 Cr | 115.97 | |
| Mar2021 | ₹1,659 Cr | - | |
Compare Net Block of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹85,664.3 Cr | -0.2% | -2.3% | -14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.2% |
-2.3% |
-14.8% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses